Results
1 -
9 of
9Therapy-New Drugs, Sexually Transmitted Infections and Sexually Transmitted Diseases Molecular Pharmacology of CXCR4 Inhibition, Novel Developments in Stem Cell Mobilization Conformational-Restricted Cyclic Peptides, Mid-size Drugs Based on Peptides and Peptidomimetics Ligand-guided optimization of CXCR4 homology models for virtual screening using a multiple chemotype approach, Journal of Computer-Aided Molecular Design New antiretroviral agents, Current Infectious Disease Reports New antiretroviral drugs, Current HIV/AIDS Reports Pharmacophore modeling, atom based 3D-QSAR and Molecular docking approaches to screen C-X-C chemokine receptor type 4 antagonists as microbicides for human immunodeficiency virus-1, VirusDisease The orally bioavailable allosteric CXCR4 HIV-1 entry inhibitor AMD11070, Retrovirology Enhancement of the CXCL12/CXCR4 axis due to acquisition of gemcitabine resistance in pancreatic cancer: effect of CXCR4 antagonists, BMC Cancer